| Insider Name | Buy/Sell | Company Name | Ticker | Amount | Shares Change | |||
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2022 | Nov 29, 2022 | Erlander Mark CEO | Buy | Cardiff Oncology, Inc. | CRDF | $1.43 | $14,300 | +29.00% |
| Mar 23, 2021 | Mar 23, 2021 | Erlander Mark CEO | Buy | Cardiff Oncology, Inc. | CRDF | $10.34 | $9,980 | +6.25% |
| May 14, 2020 | May 18, 2020 | Erlander Mark CEO | Buy | Cardiff Oncology, Inc. | CRDF | $1.43 | $10,000 | +34.34% |
| Dec 14, 2016 | Dec 15, 2016 | Erlander Mark Chief Scientific Officer | Buy | Trovagene, Inc. | TROV | $2.08 | $10,375 | +50.00% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.